Webinars, Pharmaceutical

Digital Health and Digital Therapeutics: Where are we heading and why?

Digital health is becoming increasingly important within the global healthcare landscape and has considerable potential to improve patient outcomes while driving down costs.

This webinar focuses on digital therapeutics – evidence-based, clinically evaluated software for the treatment, management and prevention of diseases and disorders. Digital therapeutics are clearly differentiated from digital health and digital medicine and examples are provided to illustrate the current market situation and potential. The benefits of digital therapeutics for patients, practitioners, and providers are discussed and reimbursement pathways are considered with reference to the current situation in different countries. Drivers for the development of digital therapeutics are discussed and challenges outlined.

Watch the webinar on Connected Devices, Digital Health and Digital Therapeutics: Where are we heading and why?
Speaker(s): Marcus Bates
12 Jul 2022

Learn more about Aptar Pharma’s expertise in Digital Health

Find Out More about Aptar Digital Health

This Might Also Be of Your Interest

1 Dec 2019

The Current State of Play in Connected Devices

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Brand Differentiation

Read More
1 Jun 2018

Connected Medicine: Insights from Payers and Other Stakeholders

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Brand Differentiation

Read More
1 Dec 2017

Connected Health – An Effective Solution to Improve Patient Adherence

Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations, Brand Differentiation

Read More
1 3 4 5

Request Access

Close

Requesting access to Digital Health and Digital Therapeutics: Where are we heading and why?.

  • This field is for validation purposes and should be left unchanged.
Back To Top